{"title":"[Role of antibiotic delivery system targeting bacterial biofilm based on ε-poly- <i>L</i>-lysine and cyclodextrin in treatment of bone and joint infections].","authors":"Tiexin Liu, Junqing Lin, Xianyou Zheng","doi":"10.7507/1002-1892.202412031","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the mechanism of antibiotic delivery system targeting bacterial biofilm with linezolid (LZD) based on ε-poly- <i>L</i>-lysine (ε-PLL) and cyclodextrin (CD) (ε-PLL-CD-LZD), aiming to enhance antibiotic bioavailability, effectively penetrate and disrupt biofilm structures, and thereby improve the treatment of bone and joint infections.</p><p><strong>Methods: </strong>ε-PLL-CD-LZD was synthesized via chemical methods. The grafting rate of CD was characterized using nuclear magnetic resonance. <i>In vitro</i> biocompatibility was evaluated through live/dead cell staining after co-culturing with mouse embryonic osteoblast precursor cells (MC3T3-E1), human umbilical vein endothelial cells, and mouse embryonic fibroblast cells (3T3-L1). The biofilm-enrichment capacity of ε-PLL-CD-LZD was assessed using <i>Staphylococcus aureus</i> biofilms through enrichment studies. Its biofilm eradication efficacy was investigated via minimum inhibitory concentration (MIC) determination, scanning electron microscopy, and live/dead bacterial staining. A bone and joint infection model in male Sprague-Dawley rats was established to validate the antibacterial effects of ε-PLL-CD-LZD.</p><p><strong>Results: </strong>In ε-PLL-CD-LZD, the average grafting rate of CD reached 9.88%. The cell viability exceeded 90% after co-culturing with three types cells. The strong biofilm enrichment capability was observed with a MIC of 2 mg/L. Scanning electron microscopy observations revealed the effective disruption of biofilm structure, indicating potent biofilm eradication capacity. <i>In vivo</i> rat experiments demonstrated that ε-PLL-CD-LZD significantly reduced bacterial load and infection positivity rate at the lesion site ( <i>P</i><0.05).</p><p><strong>Conclusion: </strong>The ε-PLL-CD antibiotic delivery system provides a treatment strategy for bone and joint infections with high clinical translational significance. By effectively enhancing antibiotic bioavailability, penetrating, and disrupting biofilms, it demonstrated significant anti-infection effects in animal models.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"39 3","pages":"362-369"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国修复重建外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7507/1002-1892.202412031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的方法:通过化学方法合成了ε-PLL-CD-LZD。方法:通过化学方法合成了ε-PLL-CD-LZD,并利用核磁共振分析了CD的接枝率。与小鼠胚胎成骨细胞前体细胞(MC3T3-E1)、人脐静脉内皮细胞和小鼠胚胎成纤维细胞(3T3-L1)共培养后,通过活/死细胞染色评估体外生物相容性。通过富集研究,使用金黄色葡萄球菌生物膜评估了 ε-PLL-CD-LZD 的生物膜富集能力。通过最低抑菌浓度(MIC)测定、扫描电子显微镜和活/死细菌染色研究了其生物膜根除功效。为了验证ε-PLL-CD-LZD的抗菌效果,还建立了雄性Sprague-Dawley大鼠骨关节感染模型:结果:在ε-PLL-CD-LZD中,CD的平均移植率达到9.88%。与三种细胞共培养后,细胞存活率超过 90%。在 MIC 为 2 mg/L 时,可观察到较强的生物膜富集能力。扫描电子显微镜观察显示,生物膜结构被有效破坏,表明生物膜具有强大的根除能力。大鼠体内实验表明,ε-PLL-CD-LZD 能显著降低病变部位的细菌负荷和感染阳性率(PConclusion:ε-PLL-CD抗生素递送系统为骨关节感染提供了一种治疗策略,具有很高的临床转化意义。通过有效提高抗生素的生物利用度、渗透和破坏生物膜,它在动物模型中显示出了显著的抗感染效果。
[Role of antibiotic delivery system targeting bacterial biofilm based on ε-poly- L-lysine and cyclodextrin in treatment of bone and joint infections].
Objective: To explore the mechanism of antibiotic delivery system targeting bacterial biofilm with linezolid (LZD) based on ε-poly- L-lysine (ε-PLL) and cyclodextrin (CD) (ε-PLL-CD-LZD), aiming to enhance antibiotic bioavailability, effectively penetrate and disrupt biofilm structures, and thereby improve the treatment of bone and joint infections.
Methods: ε-PLL-CD-LZD was synthesized via chemical methods. The grafting rate of CD was characterized using nuclear magnetic resonance. In vitro biocompatibility was evaluated through live/dead cell staining after co-culturing with mouse embryonic osteoblast precursor cells (MC3T3-E1), human umbilical vein endothelial cells, and mouse embryonic fibroblast cells (3T3-L1). The biofilm-enrichment capacity of ε-PLL-CD-LZD was assessed using Staphylococcus aureus biofilms through enrichment studies. Its biofilm eradication efficacy was investigated via minimum inhibitory concentration (MIC) determination, scanning electron microscopy, and live/dead bacterial staining. A bone and joint infection model in male Sprague-Dawley rats was established to validate the antibacterial effects of ε-PLL-CD-LZD.
Results: In ε-PLL-CD-LZD, the average grafting rate of CD reached 9.88%. The cell viability exceeded 90% after co-culturing with three types cells. The strong biofilm enrichment capability was observed with a MIC of 2 mg/L. Scanning electron microscopy observations revealed the effective disruption of biofilm structure, indicating potent biofilm eradication capacity. In vivo rat experiments demonstrated that ε-PLL-CD-LZD significantly reduced bacterial load and infection positivity rate at the lesion site ( P<0.05).
Conclusion: The ε-PLL-CD antibiotic delivery system provides a treatment strategy for bone and joint infections with high clinical translational significance. By effectively enhancing antibiotic bioavailability, penetrating, and disrupting biofilms, it demonstrated significant anti-infection effects in animal models.